Literature DB >> 28538627

Early heparin administration after traumatic brain injury: Prolonged cognitive recovery associated with reduced cerebral edema and neutrophil sequestration.

Katsuhiro Nagata1, Kevin D Browne, Yujin Suto, Kenichiro Kumasaka, John Cognetti, Victoria E Johnson, Joshua Marks, Douglas H Smith, Jose L Pascual.   

Abstract

BACKGROUND: Early administration of unfractionated heparin (UFH) after traumatic brain injury (TBI) reduces early in vivo circulating leukocytes (LEUs) in peri-injury penumbral brain tissue, enhancing cognitive recovery 2 days after injury. It remains unclear how long this effect lasts and if this is related to persistently accumulating LEUs in penumbral brain tissue. We hypothesized that UFH reduces LEU brain tissue sequestration resulting in prolonged cognitive recovery.
METHODS: CD1 male mice underwent either TBI by controlled cortical impact (CCI) or sham craniotomy. Unfractionated heparin (75 or 225 U/kg) or vehicle was repeatedly administered after TBI. Neurologic function (Garcia Neurological Test [maximum score = 18]) and body weight loss ratios were evaluated at 24 hours to 96 hours after TBI. Brain and lung wet-to-dry ratios, hemoglobin levels, and brain LEU sequestration (Ly6G immunohistochemistry) were evaluated 96 hours postmortem. Analysis of variance with Bonferroni correction determined significance (p < 0.05).
RESULTS: Compared with untreated CCI animals (24 hours, 14.7 ± 1.0; 48 hours, 15.5 ± 0.7; 72 hours, 15.0 ± 0.8; 96 hours, 16.5 ± 0.9), UFH75 (24 hours, 16.0 ± 1.0, p < 0.01; 48 hours, 16.5 ± 0.7, p < 0.05; 72 hours, 17.1 ± 0.6, p < 0.01; 96 hours, 17.4 ± 0.7, p < 0.05) increased cognitive recovery throughout the entire observation period after TBI. At 48 hours, UFH225 significantly worsened body weight loss (10.2 ± 4.7%) as compared with uninjured animals (5.5 ± 2.9%, p < 0.05). Both UFH75 (60.8 ± 40.9 PMNs per high-power field [HPF], p < 0.05) and UFH225 (36.0 ± 17.6 PMNs/HPF, p < 0.01) significantly decreased brain neutrophil sequestration found in untreated CCI animals (124.2 ± 44.1 PMNs/HPF) 96 hours after TBI. Compared with untreated CCI animals (78.8 ± 0.8%), UFH75 (77.3 ± 0.6%, p = 0.04) reduced cerebral edema to uninjured levels (77.4 ± 0.6%, p = 0.04 vs. CCI). Only UFH225 (10.6 ± 1.2 g/dL) resulted in lower hemoglobin than in uninjured animals (13.0 ± 1.2 g/dL, p < 0.05).
CONCLUSIONS: Heparin after TBI reduces tissue LEU sequestration and edema in injured brain for up to 4 days. This is associated with persistent improved cognitive recovery, but only when low-dose UFH is given. Early administration of UFH following TBI may blunt LEU-related cerebral swelling and slow progression of secondary brain injury.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28538627      PMCID: PMC9351989          DOI: 10.1097/TA.0000000000001590

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.697


  35 in total

1.  Unfractionated heparin after TBI reduces in vivo cerebrovascular inflammation, brain edema and accelerates cognitive recovery.

Authors:  Katsuhiro Nagata; Kenichiro Kumasaka; Kevin D Browne; Shengjie Li; Jesse St-Pierre; John Cognetti; Joshua Marks; Victoria E Johnson; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2016-12       Impact factor: 3.313

2.  Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.

Authors:  Narayanam V Rao; Brian Argyle; Xiaoyu Xu; Paul R Reynolds; Jeanine M Walenga; Margaret Prechel; Glenn D Prestwich; Robert B MacArthur; Bradford B Walters; John R Hoidal; Thomas P Kennedy
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-07       Impact factor: 4.249

3.  Enoxaparin ameliorates post-traumatic brain injury edema and neurologic recovery, reducing cerebral leukocyte endothelial interactions and vessel permeability in vivo.

Authors:  Shengjie Li; Joshua A Marks; Rachel Eisenstadt; Kenichiro Kumasaka; Davoud Samadi; Victoria E Johnson; Daniel N Holena; Steven R Allen; Kevin D Browne; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2015-07       Impact factor: 3.313

4.  Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation.

Authors:  J H Garcia; S Wagner; K F Liu; X J Hu
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

5.  Heparin Attenuates the Expression of TNFalpha-induced Cerebral Endothelial Cell Adhesion Molecule.

Authors:  Jeong Ho Lee; Chul Hoon Kim; Gi Ho Seo; Jinu Lee; Joo Hee Kim; Dong Goo Kim; Young Soo Ahn
Journal:  Korean J Physiol Pharmacol       Date:  2008-10-31       Impact factor: 2.016

6.  Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank.

Authors:  M Margaret Knudson; Danagra G Ikossi; Linda Khaw; Diane Morabito; Larisa S Speetzen
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

Review 7.  Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.

Authors:  Jean-Marie Stutzmann; Veronique Mary; Florence Wahl; Odile Grosjean-Piot; André Uzan; Jeremy Pratt
Journal:  CNS Drug Rev       Date:  2002

8.  Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery.

Authors:  Shengjie Li; Rachel Eisenstadt; Kenichiro Kumasaka; Victoria E Johnson; Joshua Marks; Katsuhiro Nagata; Kevin D Browne; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2016-03       Impact factor: 3.313

9.  Oxidative burst of circulating neutrophils following traumatic brain injury in human.

Authors:  Yiliu Liao; Peng Liu; Fangyuan Guo; Zhi-Yuan Zhang; Zhiren Zhang
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

10.  Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1).

Authors:  M S Diamond; R Alon; C A Parkos; M T Quinn; T A Springer
Journal:  J Cell Biol       Date:  1995-09       Impact factor: 10.539

View more
  7 in total

1.  [Formation of gap junctions between adipose stem cells-derived Schwann cells in a rat model of dyskinesia induced by brain injury].

Authors:  Youmeng Yang; Liang Yang; Zhifei Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-06-30

2.  A concomitant bone fracture delays cognitive recovery from traumatic brain injury.

Authors:  Yujin Suto; Katsuhiro Nagata; Syed M Ahmed; Christina Jacovides; Kevin D Browne; John Cognetti; Maura T Weber; Victoria E Johnson; Ryan Leone; Lewis J Kaplan; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2018-08       Impact factor: 3.697

Review 3.  Inflammation: the link between comorbidities, genetics, and Alzheimer's disease.

Authors:  Estella A Newcombe; Judith Camats-Perna; Mallone L Silva; Nicholas Valmas; Tee Jong Huat; Rodrigo Medeiros
Journal:  J Neuroinflammation       Date:  2018-09-24       Impact factor: 8.322

4.  Sevoflurane Dampens Acute Pulmonary Inflammation via the Adenosine Receptor A2B and Heme Oxygenase-1.

Authors:  Kristian-Christos Ngamsri; Anika Fuhr; Katharina Schindler; Mariana Simelitidis; Michelle Hagen; Yi Zhang; Jutta Gamper-Tsigaras; Franziska M Konrad
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

5.  Early low-anticoagulant desulfated heparin after traumatic brain injury: Reduced brain edema and leukocyte mobilization is associated with improved watermaze learning ability weeks after injury.

Authors:  Katsuhiro Nagata; Yujin Suto; John Cognetti; Kevin D Browne; Kenichiro Kumasaka; Victoria E Johnson; Lewis Kaplan; Joshua Marks; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2018-05       Impact factor: 3.697

Review 6.  Heparin: The Silver Bullet of Aneurysmal Subarachnoid Hemorrhage?

Authors:  Nicolas K Khattar; Robert F James
Journal:  Front Neurol       Date:  2018-03-27       Impact factor: 4.003

7.  Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation.

Authors:  Kristian-Christos Ngamsri; Christoph Jans; Rizki A Putri; Katharina Schindler; Jutta Gamper-Tsigaras; Claudia Eggstein; David Köhler; Franziska M Konrad
Journal:  Front Immunol       Date:  2020-03-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.